ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » New Jersey » Nephrology

Top Nephrology Prescribers in New Jersey

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
WONIL PARK M.D.

Nephrology

14,389

$873K

607
566 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

42%
prescriptions for brand name drugs

Avg: 34%

$61
Average prescription price

Avg: $121

JAYESHKUMAR PATEL M.D.

Nephrology

11,243

$639K

340
268 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 34%

$57
Average prescription price

Avg: $121

STEPHEN THOMSEN MD

Nephrology

9,669

$2.11M

694
611 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

59%
prescriptions for brand name drugs

Avg: 34%

$219
Average prescription price

Avg: $121

FOUAD ALBANA

Nephrology

9,439

$531K

295
184 are 65+

31%
patients receiving schedule two controlled substances

Avg: 3%

12%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

26%
prescriptions for brand name drugs

Avg: 34%

$56
Average prescription price

Avg: $121

KYU WANG MD

Nephrology

7,325

$470K

535
479 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 34%

$64
Average prescription price

Avg: $121

ALEXANDER SWAN MD

Nephrology

7,218

$892K

315
198 are 65+

9%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 34%

$124
Average prescription price

Avg: $121

BIKRAMJIT SINGH M.D

Nephrology

7,132

$770K

523
427 are 65+

6%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 34%

$108
Average prescription price

Avg: $121

JASBIR KASURI M.D.

Nephrology

6,181

$566K

308
211 are 65+

20%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 34%

$92
Average prescription price

Avg: $121

SAMIR SUTARIA MD

Nephrology

5,915

$750K

360
276 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

3%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

39%
prescriptions for brand name drugs

Avg: 34%

$127
Average prescription price

Avg: $121

JAMES NAJARIAN M.D.

Nephrology

5,808

$478K

502
449 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 34%

$82
Average prescription price

Avg: $121

ROBERT ARNOLD MD

Nephrology

5,692

$769K

321
274 are 65+

12%
patients receiving schedule two controlled substances

Avg: 3%

5%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 34%

$135
Average prescription price

Avg: $121

SADANAND PALEKAR MD

Nephrology

5,685

$745K

322
108 are 65+

3%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 34%

$131
Average prescription price

Avg: $121

STUART HOMER MD

Nephrology

5,418

$600K

314
256 are 65+

5%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 34%

$111
Average prescription price

Avg: $121

ARTHUR SANTIAGO M.D.

Nephrology

5,373

$407K

333
263 are 65+

16%
patients receiving schedule two controlled substances

Avg: 3%

10%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

29%
prescriptions for brand name drugs

Avg: 34%

$76
Average prescription price

Avg: $121

JEFFREY KOZLOWSKI MD

Nephrology

5,362

$717K

372
330 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

36%
prescriptions for brand name drugs

Avg: 34%

$134
Average prescription price

Avg: $121

CHARLES GELBER MD

Nephrology

5,097

$443K

385
365 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

33%
prescriptions for brand name drugs

Avg: 34%

$87
Average prescription price

Avg: $121

ANU CHAUDHRY MD

Nephrology

5,034

$472K

253
204 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 34%

$94
Average prescription price

Avg: $121

STEVEN GUDIS M.D.

Nephrology

4,690

$382K

416
357 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

9%
patients receiving schedule three controlled substances

Avg: 1%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 34%

$81
Average prescription price

Avg: $121

HEATHER LEFKOWITZ MD

Nephrology

4,644

$692K

380
138 are 65+

11%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

35%
prescriptions for brand name drugs

Avg: 34%

$149
Average prescription price

Avg: $121

SANFORD COOPER MD

Nephrology

4,602

$809K

388
179 are 65+

10%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

37%
prescriptions for brand name drugs

Avg: 34%

$176
Average prescription price

Avg: $121

LLOYD ALTERMAN MD

Nephrology

4,588

$391K

424
399 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

4%
patients receiving schedule three controlled substances

Avg: 1%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

32%
prescriptions for brand name drugs

Avg: 34%

$85
Average prescription price

Avg: $121

JEFFREY FELDMAN MD

Nephrology

4,545

$711K

171
148 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

55%
prescriptions for brand name drugs

Avg: 34%

$156
Average prescription price

Avg: $121

JOSEPH PITONE D.O.

Nephrology

4,490

$507K

516
386 are 65+

4%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

30%
prescriptions for brand name drugs

Avg: 34%

$113
Average prescription price

Avg: $121

MICHAEL GUTKIN M.D.

Nephrology

4,428

$433K

342
297 are 65+

7%
patients receiving schedule two controlled substances

Avg: 3%

6%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

31%
prescriptions for brand name drugs

Avg: 34%

$98
Average prescription price

Avg: $121

LAWRENCE BYRD M.D.

Nephrology

4,124

$738K

494
439 are 65+

0%
patients receiving schedule two controlled substances

Avg: 3%

0%
patients receiving schedule three controlled substances

Avg: 1%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 0%

57%
prescriptions for brand name drugs

Avg: 34%

$179
Average prescription price

Avg: $121

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank